![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 21, 2015 4:40:29 PM
Since there is a significant movement today, here is a quick update. As I have said previously, this stock is getting attention from significant traders, and therefore, volatility should be expected. TNXP closed very strong today with ‘seeking alpha’ articles.
http://seekingalpha.com/article/3339185-tonix-its-blockbuster-headache-remedy-two-2015-catalysts-and-two-post-offering-valuations
http://seekingalpha.com/article/3338995-insider-buying-in-tonix-should-investors-follow-suit
For those, who missed my previous analysis for this stock, here is the link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=115498860
General Updates:
a) The bulls continue to dominate on 30 minutes and hourly chart. Daily chart confirms trend reversal in progress. Few indicators for daily chart support this.
b) This stock likes being in overbought/oversold levels for extended time as we have noted from past. I am not much worried looking at these indicators at this point.
c) Intraday chart is of prominence for this stock, to identify buy and sell points. What we saw today is a new trend line formation, when price broke 9.32 levels. I have drawn the new trend lines ( in black in 5 min chart ) below. We do not know how long this trend line would continue, but TNXP is known for steep trend lines running into days.
d) Immediate support points would be 8.75-8.85 area,9.35-9.45 and lower trend line.
e) Following would be a nice resistance area for this stock – 9.8ish zone.
f) The daily chart has got more room to run without consolidation, I am hoping this to go above 10$ in coming days, and 12$+ in few weeks/months. If there is pullback, we could expect to see the pullback within trend line. The breach of trend line with pps dropping below lower trendline should be considered bearish. In my opinion, we are few days ahead of this scenario.
I continue to buy/sell TNXP following the trend lines and other indicators. My analysis shouldn't be taken as is, since i could be completely wrong.Trade smart, buy low and sell high. Do your due diligence.
Posting 5 min chart and daily chart today.
![](http://i.imgur.com/7w5u4rZ.png)
![](http://i.imgur.com/W5lbw7t.png)
Thanks
blackdeath
Recent TNXP News
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 06/28/2024 08:05:00 PM
- Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering • GlobeNewswire Inc. • 06/27/2024 12:36:51 PM
- Tonix Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 06/26/2024 08:40:16 PM
- Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 06/26/2024 07:13:29 PM
- Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024 • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 12:05:23 PM
- Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya™ for the Management of Fibromyalgia • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
- Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS) • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Tonix Pharmaceuticals Presented Poster of Tonmya™ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024 • GlobeNewswire Inc. • 06/17/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/14/2024 09:25:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 09:24:27 PM
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 06/13/2024 09:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 09:01:03 PM
- Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 06/12/2024 01:00:00 PM
- Tonix Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 06/11/2024 09:17:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/11/2024 08:49:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 12:53:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 03:21:23 PM
- Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split • GlobeNewswire Inc. • 06/06/2024 03:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 12:05:39 PM
- Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024 • GlobeNewswire Inc. • 06/06/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024 • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:05:27 PM
- Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 12:05:48 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM